Form 13-F position report

ESSA PHARMA INC

Reported by Magnus Financial Group LLC

EPIX CUSIP 29668H708 Manager CIK 0001765216

Reported 0 shares, down 55,206 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2025
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 5 Through Q4 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-12-31 98819
2025-03-31 87225
2025-06-30 93850
2025-09-30 10544
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for ESSA PHARMA INC held by Magnus Financial Group LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -55,206 (-100.0%) 0 $0 2026-01-07
Q3 2025 Unchanged 55,206 0 (0.0%) < 0.01% $10,544 2025-10-28
Q2 2025 Unchanged 55,206 0 (0.0%) < 0.01% $93,850 2025-07-16
Q1 2025 Unchanged 55,206 0 (0.0%) < 0.01% $87,225 2025-04-11
Q4 2024 New 55,206 +55,206 (0.0%) < 0.01% $98,819 2025-01-17

Who else reported the position

32 managers reported ESSA PHARMA INC for Q4 2025.

Managers reporting ESSA PHARMA INC in Q4 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Shay Capital LLC Reduced 0 -536,533 0 $0 4 qtrs
Belvedere Trading LLC Reduced 0 -15,201 0 $0 2 qtrs
BVF INC IL Reduced 0 -11,668,473 0 $0 31 qtrs
TWO SIGMA ADVISERS LP Reduced 0 -214,800 0 $0 5 qtrs
SBI Securities Co Ltd Reduced 0 -16 0 $0 2 qtrs
CIBC Private Wealth Group LLC Reduced 0 -2,500 0 $0 8 qtrs
CSS LLC IL Reduced 0 -103,488 0 $0 2 qtrs
Beaumont Capital Management LLC Reduced 0 -28,225 0 $0 2 qtrs
UBS Group AG Reduced 0 -5,470 0 $0 25 qtrs
ROYAL BANK OF CANADA Reduced 0 -19,831 0 $0 31 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2025
Filed
January 07, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.